Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Dr Beth Psaila, who has won a prestigious Fellowship at the L’Oréal-UNESCO UK and Ireland For Women In Science awards. She was one of five scientists to receive the highly competitive award.

Beth (second from right) with other winners and Prof Dame Carol Robinson

The annual Fellowships programme provides £15,000 of flexible financial support for outstanding female postdoctoral researchers to continue research in their fields, as part of a wider L’Oréal-UNESCO programme aimed at supporting and increasing the number of women working in STEM professions in the UK, where 85% of jobs are held by men.

Dr Beth Psaila (WIMM-NDCLS) is a haematologist examining the role of blood cells in the bone marrow, known as megakaryocytes, in a rare but fatal disease called Myelofibrosis which destroys the bone marrow. Most patients live for fewer than five years after diagnosis, and 20% develop blood cancer. Current treatments help symptoms but do not cure the condition or improve survival. The condition is triggered by a mutation in a key gene called JAK2, and better understanding how the disease develops at a genetic level could help in the design of new treatments.

Read more ....

Similar stories

General anaesthesia should be available for dying patients - medical and ethical experts

General Research

General anaesthesia should be more widely available for patients at the end of their lives, according to Oxford experts in ethics and anaesthesia, according to a paper published by Anaesthesia (a journal of the Association of Anaesthetists).

Risk of rare blood clotting higher for COVID-19 than for vaccines

Coronavirus COVID-19 Research

COVID-19 leads to a several-times higher risk of cerebral venous thrombosis (CVT) blood clots than current COVID-19 vaccines.

Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19

Clinical Trials Coronavirus COVID-19 Research

Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the PRINCIPLE trial in 1,779 participants.

Link between COVID-19 infection and subsequent mental health and neurological conditions found

Coronavirus COVID-19 General Research

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders.

New national study of long-term impacts of debilitating lung damage from COVID-19

Coronavirus COVID-19 General Research

A new national study will investigate the long-term effects of lung inflammation and scarring from COVID-19. The study, launched with £2 million of funding from UK Research and Innovation (UKRI), aims to develop treatment strategies and prevent disability.